Abeona Therapeutics (NASDAQ:ABEO) initiated with Buy rating and $17 (70% upside) price target at Mizuho Securities.
Sarepta Therapeutics (NASDAQ:SRPT) initiated with Outperform rating and $170 (39% upside) price target at Bernstein.
Elanco Animal Health (NYSE:ELAN) initiated with Hold rating at Craig Hallum.
Alder Biopharmaceuticals (NASDAQ:ALDR) downgraded to Neutral with a $15 (12% upside) price target at Mizuho.
Aphria (OTCQB:APHQF) downgraded to Sell with a C$19 (4% downside risk) price target at Veritas.
Allscripts (NASDAQ:MDRX) downgraded to Neutral at Evercore ISI.
Molina Healthcare (NYSE:MOH) downgraded to Hold with a $152 (10% upside) price target at Jefferies. Shares down a fraction premarket.
Immune Design (NASDAQ:IMDZ) downgraded to Market Perform at Leerink Partners following company's announced termination of internal development of CMB305.
Subscribe for full text news in your inbox